Legal Opinion

In re Flonase Antitrust Litigation

District Court, E.D. Pennsylvania

Decided June 18, 2012No. Civil Action No. 08-CV-3301PublishedCited by 22 opinions

1Opinion of the Court

MEMORANDUM

ANITA B. BRODY, District Judge.

Plaintiffs A.F. of L.-A.G.C. Building Trades Welfare Plan (“AFL”), IBEW-NECA Local 505 Health & Welfare Plan (“IBEW”), Painters District Council No. 30 Health & Welfare Fund (“Painters”), and Andrea Kehoe (“Kehoe”), collectively “Indirect Purchasers,” are indirect purchasers of the prescription drug Flonase and its generic equivalent. Flonase is the brand-name version of fluticasone propionate (“FP”) — a steroid nasal spray produced by Defendant SmithKline Beecham Corporation, doing business as GlaxoSmithKline PLC (“GSK”). Indirect Purchasers allege…

2Cases cited53 opinions

  1. Daubert v. Merrell Dow Pharmaceuticals, Inc.Supreme Court of the United States · 1993
  2. Lujan v. National Wildlife FederationSupreme Court of the United States · 1990
  3. Amchem Products, Inc. v. WindsorSupreme Court of the United States · 1997
  4. Wal-Mart Stores, Inc. v. DukesSupreme Court of the United States · 2011
  5. O'Shea v. LittletonSupreme Court of the United States · 1974

48 more not listed; retrieve them via the Exa API.

3Cited by22 opinions

  1. In re Niaspan Antitrust LitigationDistrict Court, E.D. Pennsylvania · 2014
  2. Dial Corp. v. News Corp.District Court, S.D. New York · 2015
  3. In re Nexium (Esomeprazole) Antitrust LitigationDistrict Court, D. Massachusetts · 2013
  4. In re Processed Egg Products Antitrust LitigationDistrict Court, E.D. Pennsylvania · 2015
  5. Medical Mutual of Ohio v. SmithKline Beecham Corp.District Court, E.D. Pennsylvania · 2013

17 more not listed; retrieve them via the Exa API.

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API